MY195264A - Granules Containing Besifovir Dipivoxil or Pharmaceutically Acceptable Salt Thereof, Pharmaceutical Composition Comprising Granules, And Preparation Method Therefor - Google Patents

Granules Containing Besifovir Dipivoxil or Pharmaceutically Acceptable Salt Thereof, Pharmaceutical Composition Comprising Granules, And Preparation Method Therefor

Info

Publication number
MY195264A
MY195264A MYPI2019004745A MYPI2019004745A MY195264A MY 195264 A MY195264 A MY 195264A MY PI2019004745 A MYPI2019004745 A MY PI2019004745A MY PI2019004745 A MYPI2019004745 A MY PI2019004745A MY 195264 A MY195264 A MY 195264A
Authority
MY
Malaysia
Prior art keywords
granules
besifovir
dipivoxil
preparation
pharmaceutically acceptable
Prior art date
Application number
MYPI2019004745A
Inventor
Jae-Hoon Kang
Sang Young Lee
Kyu Ho Jeong
Tae Kwang Kim
Original Assignee
Ildong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ildong Pharmaceutical Co Ltd filed Critical Ildong Pharmaceutical Co Ltd
Publication of MY195264A publication Critical patent/MY195264A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to: granules containing besifovir dipivoxil or a pharmaceutically acceptable salt thereof, and having a masked bitter taste and improved productivity; a pharmaceutical composition comprising the granules; and a preparation method therefor. (Figure 1)
MYPI2019004745A 2017-03-07 2018-03-06 Granules Containing Besifovir Dipivoxil or Pharmaceutically Acceptable Salt Thereof, Pharmaceutical Composition Comprising Granules, And Preparation Method Therefor MY195264A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170028912A KR101899773B1 (en) 2017-03-07 2017-03-07 Granules comprising besifovir dipivoxil or pharmaceutical acceptable salts thereof, a pharmaceutical composition comprising the same and a method for preparing the same
PCT/KR2018/002659 WO2018164458A1 (en) 2017-03-07 2018-03-06 Granules containing besifovir dipivoxil or pharmaceutically acceptable salt thereof, pharmaceutical composition comprising granules, and preparation method therefor

Publications (1)

Publication Number Publication Date
MY195264A true MY195264A (en) 2023-01-11

Family

ID=63448573

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019004745A MY195264A (en) 2017-03-07 2018-03-06 Granules Containing Besifovir Dipivoxil or Pharmaceutically Acceptable Salt Thereof, Pharmaceutical Composition Comprising Granules, And Preparation Method Therefor

Country Status (7)

Country Link
KR (1) KR101899773B1 (en)
CN (1) CN110582272A (en)
MY (1) MY195264A (en)
PH (1) PH12019501967A1 (en)
SG (1) SG11201907826YA (en)
TW (1) TWI786092B (en)
WO (1) WO2018164458A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193682C (en) * 1987-05-14 2000-07-04 Glaxo Group Ltd Coated Cefuroxime Maxetil Composition.
KR100676075B1 (en) * 2005-02-17 2007-02-01 한국유나이티드제약 주식회사 A Pellet Agent Containing Clarithromycin for oral suspension
TWI384986B (en) * 2007-01-17 2013-02-11 Lg Life Sciences Ltd Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same
WO2010143207A1 (en) * 2009-06-11 2010-12-16 Rubicon Research Private Limited Taste-masked oral formulations of influenza antivirals
KR101814895B1 (en) * 2013-06-04 2018-01-04 바이옴 바이오사이언스 피브이티. 엘티디. Coated particles and compositions comprising same
UY36298A (en) 2014-09-16 2016-04-29 Gilead Science Inc SOLID FORMS OF A TOLL TYPE RECEIVER MODULATOR
CA2978188C (en) 2015-03-04 2020-05-12 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
JP2018512428A (en) * 2015-04-07 2018-05-17 スプリング バンク ファーマシューティカルズ，インコーポレイテッド Compositions and methods for the treatment of HBV infection

Also Published As

Publication number Publication date
KR20180102375A (en) 2018-09-17
WO2018164458A1 (en) 2018-09-13
TWI786092B (en) 2022-12-11
CN110582272A (en) 2019-12-17
TW201832759A (en) 2018-09-16
PH12019501967A1 (en) 2020-06-15
KR101899773B1 (en) 2018-09-18
SG11201907826YA (en) 2019-09-27

Similar Documents

Publication Publication Date Title
PH12018500975A1 (en) 7-(thiazol-5-yl) pyrrolopyrimidine compound as tlr7 agonist
MX2020012966A (en) Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and sglt-2 inhibitor and preparation methods and uses thereof.
PH12016501310A1 (en) Pharmaceutical compositions comprising azd9291
MX2020002271A (en) Pharmaceutical compositions comprising sepiapterin and uses thereof.
PH12019501811A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
MX2020007554A (en) Pharmaceutical formulation comprising esomeprazole and sodium bicarbonate.
CR20220215A (en) Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases
PH12019501955A1 (en) Tri-cycle compound and applications thereof
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
MX2019001634A (en) Amide compounds, pharmaceutical compositions thereof, and methods of using the same.
TR201721505A2 (en) The combination comprising linagliptin and metformin
MX2018008153A (en) C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same.
EP3648745A4 (en) Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
EA202090913A1 (en) COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON
AU2015280874A1 (en) Novel heterocyclic compound
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MY195264A (en) Granules Containing Besifovir Dipivoxil or Pharmaceutically Acceptable Salt Thereof, Pharmaceutical Composition Comprising Granules, And Preparation Method Therefor
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
WO2018033742A3 (en) Cytisine derivatives for the treatment of addiction
WO2018119108A8 (en) Solid pharmaceutical formulations of asimadoline
WO2019059868A3 (en) Pharmaceutical combinations comprising tenofovir, emtricitabine and efavirenz
WO2018193415A9 (en) Process for the preparation of pirlindole enantiomers and its salts
PH12018500946A1 (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof